Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents

Tumor lysis syndrome (TLS) is an uncommon but potentially life‐threatening complication associated with the treatment of some cancers. If left untreated, TLS may result in acute renal failure, cardiac dysrhythmia, neurologic complications, seizures, or death. Tumor lysis syndrome is most commonly ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheson, Bruce D., Heitner Enschede, Sari, Cerri, Elisa, Desai, Monali, Potluri, Jalaja, Lamanna, Nicole, Tam, Constantine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2017
Materias:
Academia‐Pharma Intersect: Hematologic Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679833/
https://www.ncbi.nlm.nih.gov/pubmed/28851760
http://dx.doi.org/10.1634/theoncologist.2017-0055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679833/
https://www.ncbi.nlm.nih.gov/pubmed/28851760
http://dx.doi.org/10.1634/theoncologist.2017-0055

Ejemplares similares